May 19, 2021: B.R.I.D.G.E. is for Professors & Grad Students too!
Read our latest newsletter to learn more about B.R.I.D.G.E. and how it can help academia – Professors and Grad students.
Read our latest newsletter to learn more about B.R.I.D.G.E. and how it can help academia – Professors and Grad students.
With data starting from 1999 and around 500,000 cancer patients being added each year, the population-based cancer registries in each German federal state transfer data to the German Centre for Cancer Registry Data (ZfKD). ZfKD estimates national cancer incidence, prevalence and survival rates after assessing the completeness of the data recorded in the individual registries. The basic method is that the data are first checked for completeness of incidence and of vital status.
1. Klaus Kraywinkel, MD, MSc (Epidemiology)
Centre for Cancer Registry Data at the Robert Koch-Institute
General-Pape-Str. 62-66
D-12101 Berlin
GERMANY
Phone: +49-30187543170
Email: k.kraywinkel@rki.de
2. Please complete the contact form at:
https://www.krebsdaten.de/Krebs/DE/Content/ZfKD/Kontakt/kontakt_node.html;jsessionid=675E5BAEEA85BCACA037D83E2CF2178B.internet122
Nina Buttmann-Schweiger, MD, MSc (Epidemiology)
Centre for Cancer Registry Data at the Robert Koch-Institute
General-Pape-Str. 62-66
D-12101 Berlin
GERMANY
Phone: +49-3018754-3266
Email: ButtmannN@rki.de
1. Gerber TS, Strobl S, Marx A, Roth W, Porubsky S. Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999-2019. Front Oncol. 2024 Jan 9;13:1308989.
2. Vahl JM, Nagel G, Abou Kors T, Brand M, von Witzleben A, Sonntag M, Grages A, Theodoraki MN, Greve J, Denkinger M, Dallmeier D, Idel C, Stilgenbauer S, Hoffmann TK, Laban S. Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern Germany. Cancer Med. 2023 Dec;12(23):21426-21435.
3. Vahl JM, Nagel G, Grages A, Brand M, von Witzleben A, Sonntag M, Theodoraki MN, Greve J, Aboukors T, Denkinger M, Dallmeier D, Idel C, Hoffmann TK, Laban S. Demographics and access to head and neck cancer care in rural areas compared to urban areas in Germany. Cancer Med. 2023 Sep;12(18):18826-18836.
4. Neumeyer S, Tanaka LF, Liang LA, Klug SJ. Epidemiology of cervical cancer in elderly women: Analysis of incidence, treatment, and survival using German registry data. Cancer Medicine. 2023 Aug;12(16):17284-95.
5. Kraywinkel K, Flegar L, Huber J, Groeben C. Krebsregister in Deutschland: Was bringt die Zukunft für die Urologie? [Cancer registries in Germany: what does the future hold for urology?] Aktuelle Urol. 2023 Jun;54(3):208-212. German.
6. Tanaka LF, Figueroa SH, Popova V, Klug SJ, Buttmann-Schweiger N. The Rising Incidence of Early-Onset Colorectal Cancer. Dtsch Arztebl Int. 2023 Feb 3;120(Forthcoming):59-64.
7. Köhler F, Reese L, Hendricks A, Kastner C, Müller S, Lock JF, Germer CT, Wiegering A. Low-grade mucinous neoplasms (LAMN) of the appendix in Germany between 2011 and 2018: a nationwide analysis based on data provided by the German Center for Cancer Registry Data (ZfKD) at the Robert Koch Institute (RKI). Langenbecks Arch Surg. 2022 Dec;407(8):3615-3622.
8. Abele M, Voggel S, Bremensdorfer C, Spix C, Erdmann F, Kuhlen M, Redlich A, Ebinger M, Lang P, Schneider DT, Brecht IB. Incidences and characteristics of primary lung malignancies in childhood in Germany: An analysis of population-based data from German cancer registries. Pediatr Blood Cancer. 2022 Sep;69(9):e29744.
9. Jansen L, Moratin J, Waldmann A, Zaoui K, Holleczek B, Nennecke A, Pritzkuleit R, Plinkert PK, Hoffmann J, Arndt V. Mundhöhlen- und Pharynxkarzinome: Inzidenz, Mortalität und Überleben in Deutschland [Oral and pharyngeal cancer: incidence, mortality, and survival in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Aug;64(8):941-950. German.
10. Bedir A, Abera SF, Efremov L, Hassan L, Vordermark D, Medenwald D. Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data. Journal of cancer research and clinical oncology. 2021 May;147:1325-34.
The Egypt National Population-based Cancer Registry (NPCR) was established in 2007 and is the only source for cancer incidence in the whole of Egypt. It routinely collects patient data from peripheral population-based registries in the cancer centers of the 5 governorates. Data include patient demographics, primary tumor site, tumor morphology, stage at diagnosis, and follow-up for vital status from over one million patients.
Amal Ibrahim, MD, DrPH
Emeritus Professor of Epidemiology
National Cancer Institute, Cairo University
Director National Cancer Registry Program
13, Street 207 Maadi,
Cairo 11728
EGYPT
Phone: +2 01006030480
Email: ibrahimamalsamy@gmail.com
N/A
1. Ibrahim AS, Mikhail NN, Khaled H. Current and future incidence of childhood cancer in Egypt: results of the national population-based cancer registry. J Cancer PrevCurr Res. 2018;9(6):316-21.
2. Ibrahim AS, Nazmi N. Cancer: the growing monster in Egypt. J Cancer Prev Curr Res. 2016;6(4):217.
3. Ibrahim AS, Mikhail NN. The evolution of cancer registration in Egypt: From proportions to population-based incidence rates. SECI Oncology. 2015; 3(1):23-43.
4. Azim HA, Ibrahim AS. Breast cancer in Egypt, China and Chinese: statistics and beyond. J Thorac Dis. 2014 Jul;6(7):864-6.
5. Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H. Cancer incidence in egypt: results of the national population-based cancer registry program. J Cancer Epidemiol. 2014;2014:437971.
6. Alieldin NH, Abo-Elazm OM, Bilal D, Salem SE, Gouda E, Elmongy M, Ibrahim AS. Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis?. Journal of the Egyptian National Cancer Institute. 2014 Mar 1;26(1):23-30.
7. Soliman AS, Banerjee M, Lo AC, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Fokuda A, Harford JB, Merajver SD. High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt. Breast J. 2009 Jul-Aug;15(4):432-4.
8. Barchana M, Ibrahim AS, Mikhail N. MOS Epidemiology Group Special report: cancer incidence in Mediterranean populations. Mediterranean Oncology Society Web site. 2009.
9. Ibrahim AS, Ismail K, Hablas A, Hussein H, Elhamzawy H, Ramadan M. Cancer in Egypt, Gharbiah. Triennial Report of 2000–2002. Gharbiah Population-Based Cancer Registry. 2007.
10. Ibrahim AS. Descriptive statistics of urogenital cancer in Egypt and Asian area. Tunis Med. 2005 Dec;83 Suppl 12:15-7.
Kantar's latest NHWS, from South Korea and Taiwan, are the latest to be profiled in B.R.I.D.G.E. TO DATA. These databases provide demographic data, disease-specific measures on >165 conditions (including symptoms & comorbidities), patient-reported outcomes (including quality of life), patient attitudes, medication and healthcare resource utilization. The survey aims to collect data to show how patients view their health, their attitudes and behaviors, outcomes and their unmet needs.
Nikoletta Sternbach
Evidence Generation Lead, RWE
Cerner Enviza, an Oracle company
51 Valley Stream Pkwy
Malvern, PA 19355
USA
Email: Nikoletta.Sternbach@cernerenviza.com
Email: dl_enviza-nhwswiprequest@cernerenviza.com
Publications are in progress
Nikoletta Sternbach
Evidence Generation Lead, RWE
Cerner Enviza, an Oracle company
51 Valley Stream Pkwy
Malvern, PA 19355
USA
Email: Nikoletta.Sternbach@cernerenviza.com
Email: dl_enviza-nhwswiprequest@cernerenviza.com
Publications are in progress
The South Australian Cancer Registry (SACR) has been collecting data on cancer incidence and mortality since 1977. Pathology laboratories and health care institutions are required to notify the SACR of any cancer diagnosed at their facility. Approximately 10,000 new cancers are added each year.